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A B S T R A C T 
Background: in the last decade, new psychoactive substances including 
synthetic cannabinoids (SC) have appeared and are rapidly spreading in the 
Siberian Federal District of Russia. The determination of the individual 
composition of the synthetic cannabinoids is very important, first of all, for 
assessing the risk of harming the health of potential consumers as well as for 
determining sources of their appearance.  
Objective: to describe the types of synthetic cannabinoids, the dynamics of 
their occurrence and distribution in the illegal market of drugs in the territory of 
the Siberian Federal District (Russia) for the period from January 2009 till 
December 2018. Compare the results obtained with the SC distribution trends in 
other countries. 
Method: a retrospective analysis of databases (narcotic reports, 
chromatograms, mass-spectrums) obtained from GC-MS studies of 2142 samples 
taken from illicit trafficking in the territory of the Siberian Federal District 
(Russia) from January 2009 to December 2018 was conducted. 
Results and conclusion: during the analyzed period, 62 individual SCs of 
various types were identified in the studied samples. Of these, the AB-PINACA-
CHM, MDMB(N)-2201, CBL-2201, TMCP-2201 were found most frequently (10-
24% cases). In single cases JWH-018-Br, JWH-018-CI, JWH-019, MBA-2201 and 
QCBL(N)-2201 were identified. The share of the other identified individual SC did 
not exceed 10%. The results obtained are compared with the SC distribution trends 
in some countries of the Asia-Pacific region, the European Union and Turkey. 
Creating an objective global picture of the prevalence of SC requires a unified 
approach to the provision of relevant representative data. 
Keywords: synthetic cannabinoids, illicit drugs seizure, Siberian Federal 
District, Russia 
 
1. Introduction 
 
Synthetic cannabinoids in the illegal market of drugs are one of the world 
problems [1]. The works [2-13] demonstrate the results of the studies according to 
the types and distribution of synthetic cannabinoids in some countries of the 
Europe, middle East and the Asia-Pacific Region. In Russia, the withdrawal of 
smoking blends containing SC from illicit trafficking has been recorded since 
2009. In the Siberian Federal District of Russia, the territory of which is 5.1 mln 
sq. km. (30% of the territory of Russia), and the population is more than 19 mln 
people, the estimation of types of synthetic cannabinoids in the drug cases was 
performed by the Expert and Criminalistic Center of the Transport Administration 
of the Ministry of the Interior of the Russian Federation in the Siberian Federal 
District and the former Main Directorate of the Federal Drug Control Service of 
the Russian Federation in Krasnoyarsk Krai. A large amount of data was 
accumulated in the form of reports, databases, chromatograms and mass spectra. It 
was interesting to systematize the initial data and to perform the retrospective 
analysis of the accumulated material due to the extension of the list of dangerous 
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synthetic cannabinoids, updating of the libraries of mass spectra to identify the 
types of synthetic cannabinoids and tendencies of their distribution at the regional 
level. The latter seems to be a rather important additional factor for the formation 
of the objective problem of synthetic cannabinoids at the global level and 
development of the adequate measures for its solution. This study was performed 
with the permission of the Management of the Expert and Criminalistic Center of 
the Transport Administration of the Ministry of the Interior of the Russian 
Federation in the Siberian Federal District. 
 
2. Materials and methods 
 
2.1. Materials 
 
The samples containing synthetic cannabinoids were seized by the police 
from the user or the dealer between January 2009 and December 2018 (in all 2142 
samples). The analyzed samples, as a rule, were solid, plastic or powdery 
substances of different colors as well as dried plant fragments of different 
dispersion.  
 
2.2. Solvent and Sample preparation  
Samples for the study were milled in porcelain mortars to a homogeneous 
state. Next, sub-samples of 2-5 mg in the case of powdered substances and 10-15 
mg in the case of plant mixtures or plastic substances were extracted with 1 ml of 
methanol (purity not lower than analytical grade). The resulting solutions were 
incubated for 30 minutes at room temperature, then centrifuged to separate the 
residue and further investigated by the method of GC-MS.  
2.3. Instruments and parameters of GC-MS method 
 
Samples were studied according to recommendations [14, 15]. GC–MS 
analysis were performed with a chromatograph Kristall 5000.2 (Russia) with a 
quadrupole mass-spectrometer detector (MCD) ISQ (Thermo Scientific), a 
chromatograph Аgilent 6890 with a quadrupole mass-spectrometer detector 5973 
(Agilent Technologies). Analysis conditions: electron impact ionization (power of 
70 eV); fused silica columns 30 m in length and 0.32 mm in diameter, with a 
methylpolysiloxane phase containing 5% of phenyl groups (type HP-5MS); 
evaporator temperature - 280C; detector interface temperature – 280C; initial 
column temperature – 100C; final column temperature – 300C; rate of column 
temperature elevation – 15C/min; holding time at the final temperature - 10 min; 
carrier gas - helium; carrier gas flow rate – 1.0 ml/min; sample injection mode – 
split (Split 40:1).  
 
 
2.4. Identification of mass spectra 
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Evaluation of the similarity of the mass spectra was carried out after the 
library search. The following libraries were used: open-source: SWGDRUG, 
Cayman Spectral Library and departmental libraries of psychoactive substances 
(EKBDRUGS). The mass-spectra with the values of similarity index above 850 
units were taken into account. From the identification hypotheses proposed by the 
software, the variant with the highest value of the similarity index was chosen. At 
the following stage, a comparison was made of the presence of peaks of all 
characteristic ions and their intensities. Special attention was paid to the peak of 
the molecular ion and to the peaks of ions with intensities of more than 5% of the 
intensity of the maximum ion. Mass spectra were considered to match if the peaks 
of all characteristic ions from the library mass spectrum were present in the 
investigated mass spectrum, including the molecular ion in the absence of 
extraneous ion peaks, especially with intensities of more than 3%.  
 
3. Results and discussion 
 
JWH-018 was detected in three samples seized from illicit trafficking in 
September 2009. There are 62 types of different SC were identified in samples in 
subsequent 9 years (Table 1).  
 
Table 1.  
Number of SC containing samples seized from illicit trafficking between 
2009-2018 
 
SC name/year 2010 2011 2012 2013 2014 2015 2016 2017 2018 
Total 
number 
A-836,339 0 2 0 0 0 0 0 0 0 2 
AB-FUBINACA* 0 0 0 4 3 21 26 27 2 
83 
AB-PINACA 0 0 0 32 14 15 12 0 0 
63 
AB-PINACA-CHM 0 0 0 9 23 344 125 2 3 506 
AB-PINACA-F* 0 0 0 9 1 29 7 0 0 
46 
ACBM(N)-018 0 0 22 10 3 4 0 0 0 39 
ACBM(N)-2201* 0 0 32 49 2 0 0 0 0 83 
ACBM(N)-BZ-F* 0 0 0 0 0 7 0 0 0 7 
ACBM-018 0 0 3 2 0 0 0 0 0 5 
ACBM-022 0 0 5 0 0 0 0 0 0 5 
ACBM-2201* 0 0 18 8 0 0 0 0 0 26 
ADB-CHMINACA 0 0 0 0 3 74 19 0 0 96 
ADB-FUBINACA* 0 0 0 0 0 4 28 20 0 
52 
ADB-PINACA 0 0 0 0 2 0 2 0 0 4 
AM(N)-2201* 0 0 0 1 41 10 1 0 0 53 
AM-2201* 0 2 49 6 0 0 0 0 0 57 
AM-694* 0 6 0 0 0 0 0 0 0 6 
AMB-FUBINACA* 0 0 0 0 0 0 37 60 0 97 
BIM-018 0 0 0 0 0 6 6 0 0 12 
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BzCBM-018 0 0 0 0 0 2 0 0 0 2 
CB-13 0 0 0 0 0 0 2 0 0 2 
CBL(N)-2201* 0 0 0 0 0 9 8 0 0 17 
CBL-2201* 0 0 0 29 60 67 69 0 3 228 
CBL-BZ-F* 0 0 0 1 9 5 12 0 2 29 
CBM-018 0 0 3 2 0 0 0 0 0 5 
CP 47,497-C8  8 0 0 0 0 0 0 0 0 8 
EAM-2201* 0 0 0 8 0 1 0 0 0 9 
EDMB(N)-2201* 0 0 0 0 0 3 13 0 4 20 
JWH-018 105 7 6 33 1 0 0 0 0 152 
JWH-018-Br 0 0 0 1 0 0 0 0 0 1 
JWH-018-Cl 0 0 0 1 0 0 0 0 0 1 
JWH-019 0 0 1 0 0 0 0 0 0 1 
JWH-073 39 2 0 0 0 0 0 0 0 41 
JWH-122-F* 0 0 0 3 0 0 0 0 0 3 
JWH-203 41 35 23 2 2 0 1 0 0 104 
JWH-210 0 3 38 5 0 4 0 0 0 50 
JWH-250 41 13 1 1 0 0 0 0 0 56 
JWH-251 1 0 1 2 0 0 0 0 0 4 
JWH-307 0 0 0 0 0 6 2 0 0 8 
JWH-022 0 4 0 0 0 0 0 0 0 4 
MAM-2201* 0 0 2 32 0 0 0 0 0 34 
MBA-CHM 0 0 0 0 0 6 2 0 0 8 
MBA-2201 0 0 0 0 0 1 0 0 0 1 
MDMB(N)-2201* 0 0 0 0 0 67 96 101 204 468 
MDMB(N)-BZ-F* 0 0 0 0 0 12 4 0 0 16 
MDMB-2201* 0 0 0 0 0 0 0 0 2 2 
MDMB-BZ-F* 0 0 0 0 1 20 0 0 0 21 
MDMB(N)-073-F* 0 0 0 0 0 0 0 0 2 2 
MDMB-CHM 0 0 0 0 10 11 9 0 0 
30 
MMB(N)-2201* 0 0 0 0 7 73 45 0 2 127 
MMB-2201* 0 0 0 0 9 0 22 0 0 31 
PPA(N)-2201* 0 0 0 0 0 5 3 0 0 8 
PPA-2201* 0 0 0 0 1 7 9 0 0 17 
QCBL(N)-2201* 0 0 0 0 1 0 0 0 0 1 
QCBL-018 0 0 14 37 4 0 0 0 0 55 
QCBL-2201* 0 0 1 26 19 17 2 0 0 65 
QCBL-BZ-F* 0 0 0 1 12 0 5 0 0 18 
QCBL-CHM 0 0 0 0 4 0 0 0 0 4 
RCS-4 0 3 7 1 0 0 0 0 0 11 
TMCP-018 0 1 12 11 4 46 12 0 0 86 
TMCP-2201* 0 0 31 2 70 29 6 19 63 220 
TMCP-CHM 0 0 0 0 0 0 0 0 19 19 
* fluorinated synthetic cannabinoids. 
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MS-spectrums of the identified SCs are collected in the MS-library 
(*.msp format) and in the table 3, which are attached to this publication.  
 
A total of 3231 cases of individual SCs detection were recorded in 2142 
samples. The latter is explained by the fact that some samples contained several 
active agents (Fig. 1). 
 
 
Fig. 1. Shares of samples containing a particular amount of synthetic 
cannabinoids. 
 
Table 1 shows that the majority of samples seized during the entire period 
contained the following SC: AB-PINACA-CHM, MDMB(N)-2201, CBL-2201 
and TMCP-2201 (10-24 % cases). In single cases JWH-018-Br, JWH-018-CI, 
JWH-019, MBA-2201 and QCBL(N)-2201 were identified. The share of the other 
identified individual SC did not exceed 10%. 
To describe the type dynamics of SC, the scheme of the European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was used: Linked 
Group – Tail – Core – Linker (Fig. 2) [16].  
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Fig. 2. Structural fragments of SC according to the scheme EMCDDA. 
 
During 2010-2011, SC of the first generation from the class of 
naphthoylindoles, phenylacetylindoles and benzoylindoles were identified mostly 
in the studied samples: JWH-018, JWH-073, JWH-203, JWH-210, JWH-250, 
JWH-251, JWH-022. The share of naphthoylindoles was the biggest among the 
withdrawn samples. A good correlation of the prevalence of these types of SC in 
the territory of the SFD (Russia), Japan and South Korea is observed [6, 7].  
2012-2013 are characterized by the significant amount of SC with new tail, 
attached and connecting groups and well as core components.  
The new tail groups: 4-fluorobenzyl (AB-FUBINACA), cyclohexylmethyl 
(AB-PINACA-CHM), 5-fluorpentyl (AM-2201, MAM-2201). 
The new attached groups: adamantyl (ACBM(N)-018, ACBM(N)-2201, 
ACBM-018), tetramethylcyclopropyl (TMCP-018, TMCP-2201).  
The new connecting groups: carboxamide (ACBM-018) and carboxylate 
(QCBL-2201).  
The new core components are indazole containing SC (ACBM(N)-2201, 
ACBM(N)-018, QCBL-018, QCBL-2201). 
During this period, about 30 types of SC with similar structures were 
detected in European countries and about 50 SC in Japan [6, 16]. In South Korea 
the SC from the class of quinolinecarboxylates (QCBL-018, QCBL-2201) were 
widespread [7]. The comparative data from Turkey show that some SC 
(ACBM(N)-018), MAM-2201, TMCP-2201) were observed in 2013 and in the 
territory of the SFD (Russia) they were observed in 2012 [11]. 
Since 2014, almost complete disappearing of SC with the JWH structure 
from the illicit trafficking has been observed. The new structural element that 
appeared in 2014 is an attached 1-methoxycarbonylalkyl group in such SC as: 
MMB(N)-2201, MDMB-BZ-F, MDMB-CHM.  
In 2015-2016, almost all compounds that appeared again in trafficking were 
referred to the substances of the attached 1-methoxycarbonylalkyl group such as 
AMB-FUBINACA, MDMB(N)-2201. At the same time, there was a decrease in 
the number of cases of withdrawal of substances from the classes of indole-3-
carboxylates (QCBL-2201), indazole-3-carboxamides (ACBM(N)-2201), and 
cyclopropylindoles (TMCP-2201).  
The period 2017-2018 was characterized by a decrease in species diversity 
and a lack of SC with new structural elements. Most often in the withdrawn 
samples was found MDMB(N)2201 – SС of carboxamide group, as well as SC 
with tetramethylcyclopropyl group (TMCP-2201). 
In general, there was a significant decrease in the incidence of SCs with a 
JWH structure and an increase in the proportion of SCs of the carboxamide group 
over the study period (Fig. 3). SC-containing samples of the carboxylates group 
were the most common in 2013-2015, but have practically disappeared from illicit 
trafficking by now.  
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Fig. 3. Share of SC-containing samples of different structure seized from illegal 
circulation in the territory of the SFD (Russia) between 2010 – 2018.  
 
The fluorine-containing SC took a rather significant share of the total 
number of SC samples withdrawn in the territory of the SFD (Russia) (Table 1) 
with a higher bioactivity in comparison with their unsubstituted analogues (Fig. 4). 
Some decrease in their share in 2015 and 2016 can be explained by the wide 
distribution of AB-PINACA-CHM. The mentioned tendency was also observed in 
South Korea: it was reported that 90% of SC seized in 2013 were fluorinated, 
compared with 60% in 2012, and just 15% in 2011, with none reported before 
2011 [7].  
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Fig. 4. Share of samples with fluorinated SC, seized from illegal circulation 
in the territory of the SFD (Russia) between 2010-2018. 
 
However, a full comparative analysis of the species prevalence of the SC in 
various countries for 2010-2018 is largely difficult due to the lack of 
representativeness of the available data. Table 2 shows information on the most 
common SCs in the Siberian Federal District (Russia) and some other regions 
(countries) based on the results of this study and scientific publications [3-13, 16-
19]. 
 
Table 2.  
The cannabinoids with the highest overall quantities seized in different times 
in some territories. 
Year SC name Territory 
2010 CP 47,497-C8 JWH-073 JWH-203 JWH-250 JWH-018 SFD (Russia) 
2011 JWH-203 JWH-250 JWH-018 AM-694 JWH-022 SFD (Russia) 
2012 AM-2201 JWH-210 ACBM(N)-2201 TMCP-2201 JWH-203 SFD (Russia) 
MAM-2201 AM-1220 QCBL-018 ACBM(N)-018 TMCP-2201 Japan [6] 
2013 ACBM(N)-2201 QCBL-018 JWH-018 AB-PINACA CBL-2201 SFD (Russia) 
QCBL-2201 TMCP-2201 TMCP-018 QCBL-CHM EAM-2201 Japan [6] 
2014 TMCP-2201 CBL-2201 AM(N)-2201 AB-PINACA-CHM QCBL-2201 SFD (Russia) 
AM-2201 MDMB-CHM AB-FUBINACA MAM-2201 TMCP-2201 Europe[17] 
 
 
2015 
AB-PINACA-CHM ADB-CHMINACA MMB(N)-2201 CBL-2201 
MDMB(N)-2201 
SFD (Russia) 
ADB-FUBINACA ADB-CHMINACA AB-PINACA-CHM TMCP-018 
ACBM(N)-2201 
Europe [18] 
ADB-FUBINACA ADB-CHMINACA AB-FUBINACA AM-2201 Turkey [11] 
2016 AB-PINACA-CHM MDMB(N)-2201 CBL-2201 MMB(N)-2201 SFD (Russia) 
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AMB-FUBINACA 
CBM(N)-2201 CUMYL-4CN-BINACA AMB-FUBINACA MDMB(N)-2201 
AB-FUBINACA 
Europe [19] 
MDMB(N)-2201 ADB-FUBINACA CUMYL-4CN-BINACA ACBM(N)-2201 
ADB-CHMINACA 
Turkey [12] 
2017 MDMB(N)-2201 AMB-FUBINACA AB-FUBINACA ADB-FUBINACA 
TMCP-2201 
SFD (Russia) 
2018 MDMB(N)-2201 TMCP-2201 TMCP-CHM EDMB(N)-2201 AB-PINACA-
CHM 
SFD (Russia) 
 
4. Conclusion  
 
The analysis of the mentioned data demonstrates that the territory of the 
SFD (Russia) is not a "periphery" in the world illegal market of drugs. The 
occurrence and distribution of new types of SC has a global nature and is 
reproduced with a significant similarity in many countries, although with some 
regional specific character. Creating an objective global picture of the SC 
distribution and reducing the influence of random and local factors requires the 
development of a unified form of presenting information not only on the types of 
newly identified substances, but also on their quantities taken out of illegal traffic. 
Sharing such data can improve the understanding of the causes of differences in the 
prevalence of certain types of SC and will help directing the efforts of scientists, 
law enforcement agencies and health authorities to work with the most relevant 
substances. 
 
Appendix A. Supplementary data (Table 3, MS-library) 
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